Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Mineralys Therapeutics, Inc. | 8,300 | reported | 19 Feb 2026 | tx 16+4,962,352−4,944,593 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 19 Feb 2026 | OTHER | Mineralys Therapeutics, Inc. | 6,200 | 0.00 USD | |
| 19 Feb 2026 | OTHER | Mineralys Therapeutics, Inc. | 6,200 | 0.00 USD | |
| 19 Feb 2026 | GRANT_AWARD | Mineralys Therapeutics, Inc. | 6,200 | 0.00 USD | |
| 19 Feb 2026 | GRANT_AWARD | Mineralys Therapeutics, Inc. | 8,300 | 0.00 USD | deriv |
| 19 Feb 2026 | OTHER | Mineralys Therapeutics, Inc. | 8,300 | 0.00 USD | deriv |
| 19 Feb 2026 | OTHER | Mineralys Therapeutics, Inc. | 8,300 | 0.00 USD | deriv |
| 13 Mar 2025 | PURCHASE | Mineralys Therapeutics, Inc. | 259,259 | 13.50 USD | first after silence |
| 22 May 2024 | OTHER | Mineralys Therapeutics, Inc. | 22,000 | 0.00 USD | deriv |
| 22 May 2024 | OTHER | Mineralys Therapeutics, Inc. | 22,000 | 0.00 USD | deriv |
| 24 Jul 2024 | SALE | Mineralys Therapeutics, Inc. | 550,000 | 13.05 USD | |
| 12 Jul 2023 | OTHER | Mineralys Therapeutics, Inc. | 88,000 | 0.00 USD | deriv |
| 12 Jul 2023 | OTHER | Mineralys Therapeutics, Inc. | 44,000 | 0.00 USD | deriv |
| 14 Feb 2023 | PURCHASE | Mineralys Therapeutics, Inc. | 250,000 | 16.00 USD | |
| 14 Feb 2023 | CONVERSION | Mineralys Therapeutics, Inc. | 4,314,093 | — | |
| 14 Feb 2023 | CONVERSION | Mineralys Therapeutics, Inc. | 2,171,342 | 0.00 USD | deriv |
| 14 Feb 2023 | CONVERSION | Mineralys Therapeutics, Inc. | 2,142,751 | 0.00 USD | deriv |
1 purchase reported after at least 12 months of silence — most recent on 13 Mar 2025.